This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| collagen | |
|---|---|
| Name | Collagen |
| Classification | Structural protein |
| Discovered | 19th century |
| Subtypes | Type I, II, III, IV, V, etc. |
| Organisms | Animals |
collagen
Collagen is a structural protein family that provides mechanical strength and structural integrity to connective tissues in animals. It forms triple-helical fibrils and networks that contribute to the architecture of skin, bone, cartilage, tendon, cornea and basement membranes. Research on collagen spans molecular biology, pathology, biomaterials science and regenerative medicine with links to clinical practice, agriculture and industry.
The basic unit is a right-handed triple helix assembled from three left-handed polyproline-II-like chains, rich in glycine, proline and hydroxyproline; this motif was elucidated in studies connected to Linus Pauling, Robert Corey and mid‑20th century structural biology. Fibrillar collagens such as Type I, Type II and Type III form banded fibrils prominent in Bonobo‑like primate dermis and mammalian tendon; nonfibrillar collagens including Type IV form sheetlike networks in basement membranes characterized by association with Peter Medawar‑era tissue graft studies. The collagen superfamily includes at least 28 genetically distinct genes (COL1A1, COL2A1, COL3A1, COL4A1, COL5A1, etc.) described across comparative genomics projects involving organisms like Mus musculus and Danio rerio. Structural differences determine interaction with extracellular matrix proteins such as fibronectin, laminin, and proteoglycans influential in work by Erwin Chargaff‑era biochemical mapping and later proteomics centers such as the Wellcome Trust‑funded initiatives.
Biosynthesis begins with ribosomal translation of pro‑α chains encoded by collagen genes in the rough endoplasmic reticulum, a pathway studied using model systems at institutes like Max Planck Society laboratories. Essential post‑translational modifications include proline and lysine hydroxylation by prolyl and lysyl hydroxylases that require ascorbate, a link to clinical observations by Albert Szent-Györgyi on scurvy. Glycosylation of hydroxylysine residues and formation of interchain disulfide bonds in C‑propeptides precede triple‑helix folding mediated by molecular chaperones such as HSP47 studied in cell biology labs at Cold Spring Harbor Laboratory. Secretion, extracellular proteolytic processing by procollagen peptidases and crosslinking by lysyl oxidase complete maturation; defects in these steps were central to genetic investigations at centers like the Broad Institute and clinical genetics units.
Collagens are abundant in vertebrates, providing tensile strength to dermis, mineralized matrix to bone and load‑bearing resilience to cartilage; these roles have been examined in comparative anatomy collections at institutions such as Smithsonian Institution. In skin, fibrillar collagens interact with elastic fibers and keratinocytes influencing wound healing pathways investigated by translational teams at Mayo Clinic and Karolinska Institutet. Type IV networks underlie endothelial and epithelial basement membranes, crucial for filtration in organs like kidney glomeruli studied in nephrology clinics at Cleveland Clinic. Collagen interactions with cellular receptors such as integrins and discoidin domain receptors modulate cell adhesion, migration and signaling cascades explored in cancer biology programs at Memorial Sloan Kettering Cancer Center.
Extracellular turnover is mediated by matrix metalloproteinases (MMPs) and cathepsins regulated by tissue inhibitors of metalloproteinases (TIMPs); dysregulation is a theme in pathology work by investigators affiliated with Harvard Medical School and Johns Hopkins University. Collagen fragments serve as bioactive matrikines influencing inflammation and angiogenesis studied in immunology groups at Pasteur Institute. Ageing and mechanical wear alter collagen crosslink profiles, a phenomenon examined in gerontology research at University College London and biomechanics labs such as those at Massachusetts Institute of Technology.
Mutations in collagen genes cause heritable disorders: COL1A1/COL1A2 mutations yield osteogenesis imperfecta studied in pediatric centers like Great Ormond Street Hospital; COL3A1 defects produce vascular Ehlers–Danlos syndrome characterized by arterial fragility evaluated in vascular surgery units at St Thomas' Hospital. Autoimmune targeting of basement membrane collagens underpins diseases such as Goodpasture syndrome managed in nephrology services at Addenbrooke's Hospital. Collagen remodeling is central to fibrosis in organs like liver and lung, a pathogenic process investigated in clinical trials at National Institutes of Health and pharmaceutical programs at companies including Roche and GlaxoSmithKline.
Collagen is used in biomaterials for wound dressings, tissue engineering scaffolds and cosmetic formulations developed by biotechnology firms such as Johnson & Johnson and startup incubators in Silicon Valley. Food and nutraceutical industries employ collagen hydrolysates and gelatin from animal byproducts sourced via supply chains involving agricultural corporations and processing plants linked to trade partners like Cargill. Recombinant collagen production using yeast, plant and bacterial expression systems has been advanced in synthetic biology projects at institutions including ETH Zurich and companies such as Amyris for vegan‑compatible collagen analogs.
Early biochemical descriptions and naming emerged in the 19th century with advances in protein chemistry by scientists like Felix Hoppe-Seyler; the triple‑helix model was a landmark of 20th century structural biology tied to Linus Pauling. Contemporary research emphasizes engineered collagen mimetics, matrix mechanics in developmental biology and anti‑fibrotic therapeutics pursued at translational hubs like Stanford University and collaborative consortia funded by the European Commission. Future directions include precision medicine for collagenopathies, biofabrication of collagenous tissues using bioprinting teams at ETH Zurich and longevity research initiatives at institutes such as Salk Institute.
Category:Proteins